Seriously what were we expecting? This deal is dead in the water imo.Actually this whole sorry saga has at least been consistent. CONSISTENTLY BAD!
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%